跳至主要内容
临床试验/ACTRN12623000007639
ACTRN12623000007639尚未招募未知

Comparing dispersion of fluticasone using a novel device to a standard nasal spray in post-surgery chronic rhinosinusitis

niversity of Auckland0 个研究点目标入组 20 人开始时间: 2023年1月9日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Patients meeting the criteria of the 2020 European Position Paper (EPOS) definition of CRS patients with and without polyposis.
  • CRS patients that have undergone FESS

排除标准

  • - Current malignant or significant cardiovascular disease
  • -Current smokers, i.e. those who had smoked within the last 12 months.
  • -Diabetes treated with insulin or other prescribed medications
  • -History of kidney disease as an adult, including renal tumour or transplant
  • -History of chronic lung diseases
  • -History of recurrent lung infections
  • -History of severe hepatic disease/liver transplant/pending liver transplant.
  • -History of severe or multiple allergies, including hay-fever and perennial rhinitis
  • -Hypertension (high blood pressure) requiring medication
  • -Multiple myeloma
  • -Participants with documented or suspected, clinically significant alcohol or drug abuse
  • -Significant upper and/or lower respiratory tract infection within the previous 4 weeks
  • -Solid organ transplant

研究者

发起方
niversity of Auckland

相似试验